An in vitro model to test the contribution of advanced glycation end products to bone biomechanical properties

Bone

Volumn 42, Issue 1, 2008, Pages 139-149

  Viguet Carrin, S ^a   Farlay, D ^a   Bala, Y ^a   Munoz, F ^a   Bouxsein, M L ^b   Delmas, P D ^a  

^a UNIVERSITÉ DE LYON   (France)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Aminoguanidine; Bone strength; Enzymatic cross links of collagen; Mineral; Pentosidine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; COLLAGEN; DEOXYPYRIDINOLINE; PENTOSIDINE; PHOSPHATE BUFFERED SALINE; PYRIDINOLINE; RIBOSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE MATRIX; BONE MINERAL; BONE STRENGTH; CONCENTRATION RESPONSE; CORTICAL BONE; COW; CROSS LINKING; INFRARED SPECTROSCOPY; MICROSCOPY; NONHUMAN; PROTEIN DENATURATION; PROTEIN MODIFICATION; X RAY DIFFRACTION;

ANIMALS; BONE DENSITY; CATTLE; COLLAGEN; FEMUR; GLUCOSE; MODELS, ANIMAL; POROSITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STRESS, MECHANICAL; TOMOGRAPHY, X-RAY COMPUTED; X-RAY DIFFRACTION;

EID: 37349069143     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.08.046     Document Type: Article

References (66)

1. Alderson N.L., Chachich M.E., Frizzell N., Canning P., Metz T.O., Januszewski A., et al. Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat. Diabetologia 47 (2004) 1385-1395
2. Alderson N.L., Chachich M.E., Youssef N.N., Beattie R.J., Nachtigal M., Thorpe S.R., et al. The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats. Kidney Int 63 (2003) 2123-2133
3. Bailey A.J., Paul R.G., and Knott L. Mechanisms of maturation and ageing of collagen. Mech Ageing Dev 106 (1998) 1-56
4. Bailey A.J., Sims T.J., Avery N.C., and Halligan E.P. Non-enzymic glycation of fibrous collagen: reaction products of glucose and ribose. Biochem J 305 Pt 2 (1995) 385-390
5. Bala Y., Boivin G., Simi C., Ste-Marie L., Delmas P.D., and Meunier P.J. The microhardness of bone is only partly explained by its degree of mineralization in control and osteoporotic subjects. ASBMR 28th Annual Meeting of the American Society for Bone and Mineral Research. J Bone Miner Res vol. 21, Suppl 1 (2006) S332 Abstract M019. Philadelphia (PA)
6. Bank R.A., Krikken M., Beekman B., Stoop R., Maroudas A., Lafeber F.P., et al. A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage. Matrix Biol 16 (1997) 233-243
7. Banse X., Sims T.J., and Bailey A.J. Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. J Bone Miner Res 17 (2002) 1621-1628
8. Bayraktar H.H., Morgan E.F., Niebur G.L., Morris G.E., Wong E.K., and Keaveny T.M. Comparison of the elastic and yield properties of human femoral trabecular and cortical bone tissue. J Biomech 37 (2004) 27-35
9. Bolton W.K., Cattran D.C., Williams M.E., Adler S.G., Appel G.B., Cartwright K., et al. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol 24 (2004) 32-40
10. Boxberger J.V.D. Nonenzymatic glycation affects bone fracture by modifying creep and inelastic properties of collagen. 49 Annual Meeting of the Orthopaedic Research Society. New Orleans (2003)
11. Brownlee M., Cerami A., and Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318 (1988) 1315-1321
12. Broz J.J., Simske S.J., and Greenberg A.R. Material and compositional properties of selectively demineralized cortical bone. J Biomech 28 (1995) 1357-1368
13. Catanese III J., Iverson E.P., Ng R.K., and Keaveny T.M. Heterogeneity of the mechanical properties of demineralized bone. J Biomech 32 (1999) 1365-1369
14. Chen A.C., Temple M.M., Ng D.M., Verzijl N., DeGroot J., TeKoppele J.M., et al. Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage. Arthritis Rheum 46 (2002) 3212-3217
15. Currey J. Effects of porosity and mineral content on the Young's modulus of bone. Eur Soc Biomech 5 (1986) 104
16. Currey J.D. The mechanical consequences of variation in the mineral content of bone. J Biomech 2 (1969) 1-11
17. Currey J.D. Strain rate and mineral content in fracture models of bone. J Orthop Res 6 (1988) 32-38
18. DeGroot J. The AGE of the matrix: chemistry, consequence and cure. Curr Opin Pharmacol 4 (2004) 301-305
19. Dong X.N., and Guo X.E. The dependence of transversely isotropic elasticity of human femoral cortical bone on porosity. J Biomech 37 (2004) 1281-1287
20. Eppell S.J., Tong W., Katz J.L., Kuhn L., and Glimcher M.J. Shape and size of isolated bone mineralites measured using atomic force microscopy. J Orthop Res 19 (2001) 1027-1034
21. Eyre D.R., Paz M.A., and Gallop P.M. Cross-linking in collagen and elastin. Annu Rev Biochem 53 (1984) 717-748
22. Farlay D., Boivin G., Panczer G., Lalande A., and Meunier P.J. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. J Bone Miner Res 20 (2005) 1569-1578
23. Farlay D., Panczer G., Rey C., Delmas P.D., and Boivin G. New characteristics of bone mineral validated by infrared microspectroscopy. 28th Annual Meeting of the American Society for Bone and Mineral Research. J Bone Miner Res vol. 21, Suppl 1 (2006) S332 Abstract M022. Philadephia, PA, USA
24. Field R., McCormick R., Balasubramanian V., Sanson D., Wise J., Hixon D., et al. Tenderness variation among loin steaks from A and C maturity carcasses of heifers similar in chronological age. J Anim Sci 75 (1997) 693-699
25. Follet H., Boivin G., Rumelhart C., and Meunier P.J. The degree of mineralization is a determinant of bone strength: a study on human calcanei. Bone 34 (2004) 783-789
26. Freedman B.I., Wuerth J.P., Cartwright K., Bain R.P., Dippe S., Hershon K., et al. Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). Control Clin Trials 20 (1999) 493-510
27. Garnero P., Borel O., Gineyts E., Duboeuf F., Solberg H., Bouxsein M.L., et al. Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone 38 (2006) 300-309
28. Grandhee S.K., and Monnier V.M. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J Biol Chem 266 (1991) 11649-11653
29. Grant M.E., and Jackson D.S. Carbohydrate content of bovine collagen preparations. Biochem J 108 (1968) 587-591
30. Hammes H.P., Martin S., Federlin K., Geisen K., and Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci U S A 88 (1991) 11555-11558
31. Hein G., Weiss C., Lehmann G., Niwa T., Stein G., and Franke S. Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis 65 (2006) 101-104
32. Hernandez C.J., Tang S.Y., Baumbach B.M., Hwu P.B., Sakkee A.N., van der Ham F., et al. Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone 37 (2005) 825-832
33. Ino-ue M., Ohgiya N., and Yamamoto M. Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats. Brain Res 800 (1998) 319-322
34. Iqbal M., Kenney P.B., Al-Humadi N.H., and Klandorf H. Relationship between mechanical properties and pentosidine in tendon: effects of age, diet restriction, and aminoguanidine in broiler breeder hens. Poult Sci 79 (2000) 1338-1344
35. Knott L., and Bailey A.J. Collagen biochemistry of avian bone: comparison of bone type and skeletal site. Br Poult Sci 40 (1999) 371-379
36. Li Y.M., Steffes M., Donnelly T., Liu C., Fuh H., Basgen J., et al. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci U S A 93 (1996) 3902-3907
37. Martin R.B., and Boardman D.L. The effects of collagen fiber orientation, porosity, density, and mineralization on bovine cortical bone bending properties. J Biomech 26 (1993) 1047-1054
38. Monnier V.M., Mustata G.T., Biemel K.L., Reihl O., Lederer M.O., Zhenyu D., et al. Cross-linking of the extracellular matrix by the Maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution". Ann N Y Acad Sci 1043 (2005) 533-544
39. Pokharna H.K., and Pottenger L.A. Glycation induced crosslinking of link proteins, in vivo and in vitro. J Surg Res 94 (2000) 35-42
40. Reddy G.K., Stehno-Bittel L., Hamade S., and Enwemeka C.S. The biomechanical integrity of bone in experimental diabetes. Diabetes Res Clin Pract 54 (2001) 1-8
41. Reihsner R., and Menzel E.J. Two-dimensional stress-relaxation behavior of human skin as influenced by non-enzymatic glycation and the inhibitory agent aminoguanidine. J Biomech 31 (1998) 985-993
42. Saito M., Fujii K., Mori Y., and Marumo K. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int 17 (2006) 1514-1523
43. Saito M., Fujii K., Soshi S., and Tanaka T. Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int 17 (2006) 986-995
44. Saito M., Marumo K., Fujii K., and Ishioka N. Single-column high-performance liquid chromatographic-fluorescence detection of immature, mature, and senescent cross-links of collagen. Anal Biochem 253 (1997) 26-32
45. Sajithlal G.B., Chithra P., and Chandrakasan G. Advanced glycation end products induce crosslinking of collagen in vitro. Biochim Biophys Acta 1407 (1998) 215-224
46. Sajithlal G.B., Chithra P., and Chandrakasan G. The role of metal-catalyzed oxidation in the formation of advanced glycation end products: an in vitro study on collagen. Free Radic Biol Med 25 (1998) 265-269
47. Schaffler M.B., and Burr D.B. Stiffness of compact bone: effects of porosity and density. J Biomech 21 (1988) 13-16
48. Sell D.R., Biemel K.M., Reihl O., Lederer M.O., Strauch C.M., and Monnier V.M. Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J Biol Chem 280 (2005) 12310-12315
49. Sell D.R., Nagaraj R.H., Grandhee S.K., Odetti P., Lapolla A., Fogarty J., et al. Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Diabetes Metab Rev 7 (1991) 239-251
50. Shapiro R., McManus M.J., Zalut C., and Bunn H.F. Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem 255 (1980) 3120-3127
51. Shimizu K., Yamamuro T., Higuchi K., and Takeda T. In vitro aging of pyridinoline crosslinks in bone and tendon collagens. Nippon Geka Hokan 50 (1981) 789-795
52. Sparke A.J., Sims T.J., Avery N.C., Bailey A.J., Fleming R.H., and Whitehead C.C. Differences in composition of avian bone collagen following genetic selection for resistance to osteoporosis. Br Poult Sci 43 (2002) 127-134
53. Thornalley P.J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys 419 (2003) 31-40
54. Tong W., Glimcher M.J., Katz J.L., Kuhn L., and Eppell S.J. Size and shape of mineralites in young bovine bone measured by atomic force microscopy. Calcif Tissue Int 72 (2003) 592-598
55. Turner C.H., and Burr D.B. Basic biomechanical measurements of bone: a tutorial. Bone 14 (1993) 595-608
56. Uchiyama A., Inoue T., and Fujimoto D. Synthesis of pyridinoline during in vitro aging of bone collagen. J Biochem (Tokyo) 90 (1981) 1795-1798
57. Valcourt U., Merle B., Gineyts E., Viguet-Carrin S., Delmas P.D., and Garnero P. Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 282 (2007) 5691-5703
58. Vashishth D., Gibson G.J., Khoury J.I., Schaffler M.B., Kimura J., and Fyhrie D.P. Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28 (2001) 195-201
59. Vashishth D., W.P., and Gibson G.J. Age-related loss in bone toughness is explained by non-enzymatic glycation of collagen. 49 Annual Meeting of the Orthopaedic Research Society. New Orleans (2003)
60. Viguet-Carrin S., Garnero P., and Delmas P.D. The role of collagen in bone strength. Osteoporos Int 17 (2006) 319-336
61. Viguet-Carrin S., Roux J.P., Arlot M.E., Merabet Z., Leeming D.J., Byrjalsen I., et al. Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone 39 (2006) 1073-1079
62. Wang X., Bank R.A., TeKoppele J.M., and Agrawal C.M. The role of collagen in determining bone mechanical properties. J Orthop Res 19 (2001) 1021-1026
63. Wang X., Shen X., Li X., and Agrawal C.M. Age-related changes in the collagen network and toughness of bone. Bone 31 (2002) 1-7
64. Watkins N.G., Neglia-Fisher C.I., Dyer D.G., Thorpe S.R., and Baynes J.W. Effect of phosphate on the kinetics and specificity of glycation of protein. J Biol Chem 262 (1987) 7207-7212
65. Wolffenbuttel B.H., and Huijberts M.S. Aminoguanidine, a potential drug for the treatment of diabetic complications. Neth J Med 42 (1993) 205-208
66. Zioupos P., Currey J.D., and Hamer A.J. The role of collagen in the declining mechanical properties of aging human cortical bone. J Biomed Mater Res 45 (1999) 108-116